H19 and pulmonary arterial hypertension: Consistent with the potential role of lncRNA in PAH RV dysfunction, Omura and colleagues reported that increased expression of the lncRNA H19 correlated with RV fibrosis and cardiomyocyte hypertrophy in PAH patients and two preclinical models of RV failure [99].